India plans to cap trade margins on 137 cancer medicines, report says

India is reportedly introducing a cap on trade margins for 137 cancer medicines, a measure intended to reduce the prices patients pay.

The supplied account says the cap would be 30% of retail price from early November and that the government expects price reductions of up to 70%. It also reports an obligation for manufacturers to maintain existing supply levels.

The potential benefit is more affordable treatment, but the largest projected reduction will not necessarily apply to every medicine or patient. The official order, start date, covered products and rules for maintaining supply need to be checked before the savings can be treated as confirmed.

Sources

• User-supplied newsletter; ThePrint cited